Huaizhang Shi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Huaizhang Shi has a total of 123 co-authors. Here are the top co-authors by number of shared publications:
Shuai Lan
Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China
7 shared publicationsBowen Sun
Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China
6 shared publicationsQiaowei Wu
Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China
6 shared publicationsKaikun Yuan
Department of Neurosurgery the First Affiliated Hospital of Harbin Medical University Harbin China
5 shared publicationsPei Wu
Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, China
5 shared publications- Shancai Xu
Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
5 shared publications
Latest Publications
- Open Access
- 11 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (55) , e76553
Targeted Degradation of STING by a Neutrophil Membrane‐Coated Nanoplatform Suppresses Microglial Pyroptosis After Subarachnoid Hemorrhage
Subarachnoid hemorrhage (SAH) is a life‐threatening cerebrovascular disease in which neuroinflammation and neuronal death critically contribute to poor outcomes. Here, we identify aberrant STING activation as a key driver of microglial pyroptosis and post‐SAH injury. Transcriptomic and biochemical analyses support a close association between STING signaling and microglial pyroptosis, with MAPK signaling acting as a functionally relevant downstream pathway. Based on this mechanistic insight, we engineered MG1 peptide‐functionalized, neutrophil membrane‐coated STING‐PROTAC nanoparticles (MG1@NM‐Px) to enable blood‐brain barrier penetration, microglia‐targeted delivery, and efficient STING degradation in vivo. This catalytic degradation suppressed the inflammasome‐related activation and GSDME‐associated pyroptotic signaling, reduced pro‐inflammatory cytokine secretion, and prevented neuronal apoptosis. Histopathological examination showed preserved Nissl body integrity, while behavioral testing revealed significant improvements in neurological function. Collectively, this engineered neutrophil membrane‐coated STING‐PROTAC nanoplatform effectively degrades STING, inhibits microglial pyroptosis, and provides robust neuroprotection in SAH. This work establishes a novel biomimetic nanomedicine strategy for SAH therapy and opens new avenues for treating neuroinflammation‐related disorders.
- 11 July 2026
- Published by Wiley in Advanced Science
- Vol. 13 (55) , e76553
Open AccessTargeted Degradation of STING by a Neutrophil Membrane‐Coated Nanoplatform Suppresses Microglial Pyroptosis After Subarachnoid Hemorrhage
Subarachnoid hemorrhage (SAH) is a life‐threatening cerebrovascular disease in which neuroinflammation and neuronal death critically contribute to poor outcomes. Here, we identify aberrant STING activation as a key driver of microglial pyroptosis and post‐SAH injury. Transcriptomic and biochemical analyses support a close association between STING signaling and microglial pyroptosis, with MAPK signaling acting as a functionally relevant downstream pathway. Based on this mechanistic insight, we engineered MG1 peptide‐functionalized, neutrophil membrane‐coated STING‐PROTAC nanoparticles (MG1@NM‐Px) to enable blood‐brain barrier penetration, microglia‐targeted delivery, and efficient STING degradation in vivo. This catalytic degradation suppressed the inflammasome‐related activation and GSDME‐associated pyroptotic signaling, reduced pro‐inflammatory cytokine secretion, and prevented neuronal apoptosis. Histopathological examination showed preserved Nissl body integrity, while behavioral testing revealed significant improvements in neurological function. Collectively, this engineered neutrophil membrane‐coated STING‐PROTAC nanoplatform effectively degrades STING, inhibits microglial pyroptosis, and provides robust neuroprotection in SAH. This work establishes a novel biomimetic nanomedicine strategy for SAH therapy and opens new avenues for treating neuroinflammation‐related disorders.
- Open Access
Molecular taxonomy and spatial organization define neuronal subtypes in the mouse inferior colliculus
- Open Access
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 675
Microglia Attenuate Neuroinflammation After Subarachnoid Hemorrhage by Modulating Astrocyte Phenotypic Transformation via the RARα/Mafb/Msr1 Pathway
Neuroinflammation mediated by microglia-astrocyte interactions significantly contributes to secondary brain injury after subarachnoid hemorrhage (SAH). Retinoic acid receptor alpha (RARα) has emerged as a potential modulator of neuroinflammation. However, its specific mechanisms in the interaction between microglia and astrocytes after SAH are not yet known. This study investigated whether RARα activation might alleviate neuroinflammation post-SAH by regulating microglial-astrocytic crosstalk via the Mafb/Msr1/PI3K-Akt signaling axis. An in vivo SAH model in male Sprague-Dawley rats was established through endovascular perforation. In vitro, a microglia-astrocyte co-culture system was subjected to oxyhemoglobin treatment to mimic SAH conditions. The RARα-specific agonist Am80 was administered to activate RARα signaling. Key molecular markers (Mafb, Msr1, and PI3K/Akt), pro-/anti-inflammatory cytokines, and glial activation phenotypes were evaluated via western blotting and immunofluorescence. Functional recovery was assessed with neurobehavioral tests. Pathway-specific inhibitors were used for mechanistic validation. RARα activation markedly attenuated neuroinflammation, enhanced neurological outcomes in SAH rats, significantly decreased levels of pro-inflammatory factors, and inhibited neuroinflammation mediated by microglia. Mechanistically, Am80 was found to upregulate the transcription factor Mafb and its downstream target Msr1, thereby triggering PI3K/Akt phosphorylation. This cascade inhibited NF-κB-mediated pro-inflammatory cytokine release and enhanced anti-inflammatory factors. Critically, blockade of PI3K/Akt or knockdown of Mafb/Msr1 abolished the anti-inflammatory effects of Am80. In addition, the inflammatory factor receptors TNF-αR and IL6R were demonstrated to be important mediators of microglia and astrocyte interaction. RARα activation mitigates SAH-induced neuroinflammation by modulating microglial-astrocyte interactions through the Mafb/Msr1/PI3K-Akt pathway. Our findings identified RARα as a promising therapeutic target for ameliorating neuroinflammation and improving recovery after SAH.
- 1 January 2026
- Published by Springer Nature in Molecular Neurobiology
- Vol. 63 (1) , 675
Open AccessMicroglia Attenuate Neuroinflammation After Subarachnoid Hemorrhage by Modulating Astrocyte Phenotypic Transformation via the RARα/Mafb/Msr1 Pathway
Neuroinflammation mediated by microglia-astrocyte interactions significantly contributes to secondary brain injury after subarachnoid hemorrhage (SAH). Retinoic acid receptor alpha (RARα) has emerged as a potential modulator of neuroinflammation. However, its specific mechanisms in the interaction between microglia and astrocytes after SAH are not yet known. This study investigated whether RARα activation might alleviate neuroinflammation post-SAH by regulating microglial-astrocytic crosstalk via the Mafb/Msr1/PI3K-Akt signaling axis. An in vivo SAH model in male Sprague-Dawley rats was established through endovascular perforation. In vitro, a microglia-astrocyte co-culture system was subjected to oxyhemoglobin treatment to mimic SAH conditions. The RARα-specific agonist Am80 was administered to activate RARα signaling. Key molecular markers (Mafb, Msr1, and PI3K/Akt), pro-/anti-inflammatory cytokines, and glial activation phenotypes were evaluated via western blotting and immunofluorescence. Functional recovery was assessed with neurobehavioral tests. Pathway-specific inhibitors were used for mechanistic validation. RARα activation markedly attenuated neuroinflammation, enhanced neurological outcomes in SAH rats, significantly decreased levels of pro-inflammatory factors, and inhibited neuroinflammation mediated by microglia. Mechanistically, Am80 was found to upregulate the transcription factor Mafb and its downstream target Msr1, thereby triggering PI3K/Akt phosphorylation. This cascade inhibited NF-κB-mediated pro-inflammatory cytokine release and enhanced anti-inflammatory factors. Critically, blockade of PI3K/Akt or knockdown of Mafb/Msr1 abolished the anti-inflammatory effects of Am80. In addition, the inflammatory factor receptors TNF-αR and IL6R were demonstrated to be important mediators of microglia and astrocyte interaction. RARα activation mitigates SAH-induced neuroinflammation by modulating microglial-astrocyte interactions through the Mafb/Msr1/PI3K-Akt pathway. Our findings identified RARα as a promising therapeutic target for ameliorating neuroinflammation and improving recovery after SAH.
- Open Access
- 9 September 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (9) , 1864-1871
Educational value of remote live-streamed training in endovascular thrombectomy: dose–response and mediation analysis
Background Remote live-streamed training in endovascular thrombectomy (EVT) is a novel educational strategy. This study evaluated the dose–response relationship between training duration and clinical outcomes, and explored mediation pathways. Methods In a prospective cohort study, 1046 participants received remote EVT training, with 1010 completing follow-up. Locally Estimated Scatterplot Smoothing (LOESS) and segmented regression identified training thresholds. Participants were categorized into low (70 hours) training groups. Inverse probability of treatment weighting (IPTW) was adjusted for baseline differences. Mediation analysis examined the mechanisms of effect. Results A dose–response relationship was evident: outcome improvements accelerated after 25 hours and plateaued beyond 70 hours. After IPTW, patients treated by both medium and high training groups achieved significantly better 90-day outcomes compared with the low training group (medium vs low, adjusted β=1.54, 95% CI 0.94 to 2.15; high vs low, β=3.16, 95% CI 2.28 to 4.04, both PConclusion Remote live-streamed EVT training is significantly associated with improved 90-day functional outcomes. The greatest benefits were observed after 25 hours of training and diminishing returns beyond 70 hours. These gains are partly mediated by enhanced professional competency and improved recanalization outcomes, highlighting the importance of structured, high-quality remote training programs for optimizing neurointerventional care.
- 9 September 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (9) , 1864-1871
Open AccessEducational value of remote live-streamed training in endovascular thrombectomy: dose–response and mediation analysis
Background Remote live-streamed training in endovascular thrombectomy (EVT) is a novel educational strategy. This study evaluated the dose–response relationship between training duration and clinical outcomes, and explored mediation pathways. Methods In a prospective cohort study, 1046 participants received remote EVT training, with 1010 completing follow-up. Locally Estimated Scatterplot Smoothing (LOESS) and segmented regression identified training thresholds. Participants were categorized into low (70 hours) training groups. Inverse probability of treatment weighting (IPTW) was adjusted for baseline differences. Mediation analysis examined the mechanisms of effect. Results A dose–response relationship was evident: outcome improvements accelerated after 25 hours and plateaued beyond 70 hours. After IPTW, patients treated by both medium and high training groups achieved significantly better 90-day outcomes compared with the low training group (medium vs low, adjusted β=1.54, 95% CI 0.94 to 2.15; high vs low, β=3.16, 95% CI 2.28 to 4.04, both PConclusion Remote live-streamed EVT training is significantly associated with improved 90-day functional outcomes. The greatest benefits were observed after 25 hours of training and diminishing returns beyond 70 hours. These gains are partly mediated by enhanced professional competency and improved recanalization outcomes, highlighting the importance of structured, high-quality remote training programs for optimizing neurointerventional care.
- Open Access
- 22 April 2025
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 12, 1536912
Direct mechanical thrombectomy vs. intravenous alteplase plus mechanical thrombectomy in acute ischemic stroke with anterior circulation tandem occlusions
Background and purpose: Tandem occlusion is a significant risk factor for poor outcomes following intravenous thrombolysis. The necessity of bridging therapy [intravenous thrombolysis prior to mechanical thrombectomy (MT)] for patients with tandem occlusion remains controversial. This study assessed the safety and efficacy of direct MT vs. bridging therapy in patients with tandem occlusions in the anterior circulation.Methods: This retrospective study enrolled patients with anterior circulation tandem occlusions treated with either direct mechanical thrombectomy (MT-alone group) or intravenous alteplase thrombolysis followed by MT (bridging group) between January 2019 and March 2022. The primary outcome was prespecified as a favorable outcome [modified Rankin Scale (mRS) score of 0–2] at 90 days. Secondary outcomes included successful reperfusion, overall mortality at 90 days, and rates of symptomatic intracranial hemorrhage (SICH) and asymptomatic intracranial hemorrhage (aSICH).Results: A total of 110 patients were enrolled, with 49 in the MT-alone group and 61 in the bridging group. A favorable outcome (mRS score of 0–2) at 90 days was achieved in 25 patients (51.0%) in the MT-alone group and in 34 patients (55.7%) in the bridging group, showing no significant difference between the groups, with an adjusted odds ratio (aOR) of 1.17 (95% CI, 0.47–2.90; P = 0.743). The incidence of aSICH was higher in the bridging group than in the MT-alone group [31.1% vs. 14.3%; aOR, 2.86 (95% CI, 1.04–7.88); P = 0.042]. Rates of successful reperfusion, overall mortality at 90 days, and SICH were similar between the groups. Multivariate analysis showed that a lower baseline National Institutes of Health Stroke Scale (NIHSS) score (P = 0.005), intraprocedural tirofiban administration (P = 0.012), and internal carotid artery stent implantation (P = 0.040) were associated with a favorable outcome at 90 days.Conclusion: This study found no evidence that prior intravenous thrombolysis affects clinical or imaging outcomes in patients with acute ischemic stroke due to anterior circulation tandem occlusions after endovascular thrombectomy. Bridging therapy may be associated with an increased rate of aSICH. Intraprocedural tirofiban administration, stent implantation, and a lower baseline NIHSS score were associated with favorable outcomes.
- 22 April 2025
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 12, 1536912
Open AccessDirect mechanical thrombectomy vs. intravenous alteplase plus mechanical thrombectomy in acute ischemic stroke with anterior circulation tandem occlusions
Background and purpose: Tandem occlusion is a significant risk factor for poor outcomes following intravenous thrombolysis. The necessity of bridging therapy [intravenous thrombolysis prior to mechanical thrombectomy (MT)] for patients with tandem occlusion remains controversial. This study assessed the safety and efficacy of direct MT vs. bridging therapy in patients with tandem occlusions in the anterior circulation.Methods: This retrospective study enrolled patients with anterior circulation tandem occlusions treated with either direct mechanical thrombectomy (MT-alone group) or intravenous alteplase thrombolysis followed by MT (bridging group) between January 2019 and March 2022. The primary outcome was prespecified as a favorable outcome [modified Rankin Scale (mRS) score of 0–2] at 90 days. Secondary outcomes included successful reperfusion, overall mortality at 90 days, and rates of symptomatic intracranial hemorrhage (SICH) and asymptomatic intracranial hemorrhage (aSICH).Results: A total of 110 patients were enrolled, with 49 in the MT-alone group and 61 in the bridging group. A favorable outcome (mRS score of 0–2) at 90 days was achieved in 25 patients (51.0%) in the MT-alone group and in 34 patients (55.7%) in the bridging group, showing no significant difference between the groups, with an adjusted odds ratio (aOR) of 1.17 (95% CI, 0.47–2.90; P = 0.743). The incidence of aSICH was higher in the bridging group than in the MT-alone group [31.1% vs. 14.3%; aOR, 2.86 (95% CI, 1.04–7.88); P = 0.042]. Rates of successful reperfusion, overall mortality at 90 days, and SICH were similar between the groups. Multivariate analysis showed that a lower baseline National Institutes of Health Stroke Scale (NIHSS) score (P = 0.005), intraprocedural tirofiban administration (P = 0.012), and internal carotid artery stent implantation (P = 0.040) were associated with a favorable outcome at 90 days.Conclusion: This study found no evidence that prior intravenous thrombolysis affects clinical or imaging outcomes in patients with acute ischemic stroke due to anterior circulation tandem occlusions after endovascular thrombectomy. Bridging therapy may be associated with an increased rate of aSICH. Intraprocedural tirofiban administration, stent implantation, and a lower baseline NIHSS score were associated with favorable outcomes.
- Open Access
- 4 April 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 22 (4) , e00572
Retinoic acid-inducible gene-I aggravates neuroinflammation in early brain injury after subarachnoid hemorrhage through mediating brain microvascular endothelial cell pyroptosis
- 4 April 2025
- Published by Elsevier in Neurotherapeutics
- Vol. 22 (4) , e00572
Open AccessRetinoic acid-inducible gene-I aggravates neuroinflammation in early brain injury after subarachnoid hemorrhage through mediating brain microvascular endothelial cell pyroptosis
- Open Access
- 1 December 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (12) , 8878-8888
Reconstructive endovascular treatment of patients with ruptured distal intracranial aneurysms in posterior circulation: a retrospective cohort study
Background: Cases of ruptured distal intracranial aneurysms (DIAs) in the posterior circulation are rare. Currently, the most commonly used approach in clinical practice to treat this condition is reconstructive endovascular treatment. However, research on endovascular treatment of intracranial posterior circulation ruptured DIAs is currently lacking. This study aimed to analyze the safety and efficacy of reconstructive endovascular treatment for DIAs in the posterior circulation. Methods: A retrospective cohort study was conducted on patients with ruptured distal posterior circulation aneurysms who underwent endovascular reconstructive treatment at The First Affiliated Hospital of Harbin Medical University from September 2014 to August 2023. We collected and analyzed the patients’ characteristics, clinical outcomes, and angiographic follow-up results. Complications were determined and recorded based on the patients’ hospital records and imaging examination results. Clinical information was collected through neurological assessments and follow-up telephone interviews. Follow-up angiographic evaluations using digital subtraction angiography (DSA) were planned for 6 months after the procedure until 1-year postprocedure. Results: The procedure was successfully performed on all 49 patients. Among the patients, 16 (32.7%) were males with a median age of 59.0±12.7 years. A total of 15 (30.6%) patients used stent-assisted coiling. During hospitalization, 16 (32.7%) patients experienced complications, including 6 with hemorrhagic complications, 7 with ischemic complications, and 4 with shunt-dependent hydrocephalus. One patient had both shunt-dependent hydrocephalus and ischemic complications. Three (6.1%) patients died during hospitalization, all related to aneurysm rebleeding. All patients underwent clinical follow-up, with a median follow-up time of 39 months [interquartile range (IQR), 21.0–70.5 months]. At the last follow-up, 42 (85.7%) patients had a modified Rankin scale score of 0–2. During the follow-up period, one patient died, resulting in an overall mortality rate of 8.2% (4/49). A total of 35 surviving patients underwent angiographic follow-up, with a follow-up rate of 76.1% (35/46) and a median follow-up time of 8.5 months (IQR, 6.0–12.0 months). Among the follow-up patients, 94.3% were classified as Raymond-Roy grade 1–2, and two patients experienced residual aneurysm. Survival analysis showed a 1-year complication-free survival rate of 69.4% and a 1-year overall survival rate of 89.3%. Conclusions: This study found that the incidence of complications during hospitalization was relatively high. However, the clinical follow-up results were satisfactory, and imaging follow-up demonstrated a high aneurysm occlusion rate. In summary, endovascular treatment of ruptured DIAs in the posterior circulation is feasible, safe, and effective, but attention should still be paid to the occurrence of related complications.
- 1 December 2024
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 14 (12) , 8878-8888
Open AccessReconstructive endovascular treatment of patients with ruptured distal intracranial aneurysms in posterior circulation: a retrospective cohort study
Background: Cases of ruptured distal intracranial aneurysms (DIAs) in the posterior circulation are rare. Currently, the most commonly used approach in clinical practice to treat this condition is reconstructive endovascular treatment. However, research on endovascular treatment of intracranial posterior circulation ruptured DIAs is currently lacking. This study aimed to analyze the safety and efficacy of reconstructive endovascular treatment for DIAs in the posterior circulation. Methods: A retrospective cohort study was conducted on patients with ruptured distal posterior circulation aneurysms who underwent endovascular reconstructive treatment at The First Affiliated Hospital of Harbin Medical University from September 2014 to August 2023. We collected and analyzed the patients’ characteristics, clinical outcomes, and angiographic follow-up results. Complications were determined and recorded based on the patients’ hospital records and imaging examination results. Clinical information was collected through neurological assessments and follow-up telephone interviews. Follow-up angiographic evaluations using digital subtraction angiography (DSA) were planned for 6 months after the procedure until 1-year postprocedure. Results: The procedure was successfully performed on all 49 patients. Among the patients, 16 (32.7%) were males with a median age of 59.0±12.7 years. A total of 15 (30.6%) patients used stent-assisted coiling. During hospitalization, 16 (32.7%) patients experienced complications, including 6 with hemorrhagic complications, 7 with ischemic complications, and 4 with shunt-dependent hydrocephalus. One patient had both shunt-dependent hydrocephalus and ischemic complications. Three (6.1%) patients died during hospitalization, all related to aneurysm rebleeding. All patients underwent clinical follow-up, with a median follow-up time of 39 months [interquartile range (IQR), 21.0–70.5 months]. At the last follow-up, 42 (85.7%) patients had a modified Rankin scale score of 0–2. During the follow-up period, one patient died, resulting in an overall mortality rate of 8.2% (4/49). A total of 35 surviving patients underwent angiographic follow-up, with a follow-up rate of 76.1% (35/46) and a median follow-up time of 8.5 months (IQR, 6.0–12.0 months). Among the follow-up patients, 94.3% were classified as Raymond-Roy grade 1–2, and two patients experienced residual aneurysm. Survival analysis showed a 1-year complication-free survival rate of 69.4% and a 1-year overall survival rate of 89.3%. Conclusions: This study found that the incidence of complications during hospitalization was relatively high. However, the clinical follow-up results were satisfactory, and imaging follow-up demonstrated a high aneurysm occlusion rate. In summary, endovascular treatment of ruptured DIAs in the posterior circulation is feasible, safe, and effective, but attention should still be paid to the occurrence of related complications.
- 4 October 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 224, 846-861
BL-918 alleviates oxidative stress in rats after subarachnoid hemorrhage by promoting mitophagy through the ULK1/PINK1/Parkin pathway
- 4 October 2024
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 224, 846-861
BL-918 alleviates oxidative stress in rats after subarachnoid hemorrhage by promoting mitophagy through the ULK1/PINK1/Parkin pathway